California Senate Votes to Decriminalize Psychedelics
California lawmakers have passed Senate Bill 58, a groundbreaking piece of legislation that decriminalizes the possession and personal use of
Read more
Psilocybin
Australia Becomes First to Reclassify MDMA and Psilocybin As Medicine for Specific Uses
Australia has become the first country in the world to re-classify the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) as medicines.
Read more
Quebec Makes History As First Province in Canada to Cover Psilocybin-Assisted Psychotherapy
Last week, Quebec became the first governing medical body in Canada to publicly fund medical psilocybin-assisted psychotherapy, with advocates hoping
Read more
Revive Therapeutics Provides Update On Current Psilocybin Programs
Revive Therapeutics (CSE: RVV) this morning provided a corporate update as it pertains to its psychedelic assets. The update primarily
Read more
Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical Trial
Compass Pathways (NASDAQ: CMPS) this morning provided a brief update to the market on the latest status of its ongoing
Read more
Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract
Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with
Read more
Revive Therapeutics Files For Patent On Oral Thin Film With Psilocybin
Revive Therapeutics (CSE: RVV) this morning announced that it has successfully completed research on an oral thin film delivery system
Read more
Revive Therapeutics Enters LOI To Acquire Psilocybin Program From PharmaTher
Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a letter of intent to acquire PharmaTher Inc’s
Read more
Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics
For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh
Read more
Revive Therapeutics Completes Psilocybin Oral Thin Film Strip Product
Revive Therapeutics (CSE: RVV) has completed its oral thin film strip product for psilocybin after several months of prototyping. The
Read more